Zweig-DiMenna Associates’s Bausch Health BHC Stock Holding History

Zweig-DiMenna Associates’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,000	Closed	-$232K	–	143
2018 Q2	$232K	Sell	10,000 -5,400	-35%	-$112K	0.01%	134
2018 Q1	$245K	Buy	+15,400	New	+$287K	0.02%	117
2015 Q4	–	Sell	-186,798	Closed	-$33.3M	–	249
2015 Q3	$33.3M	Buy	186,798 +42,071	+29%	+$9.81M	1.44%	15
2015 Q2	$32.2M	Sell	144,727 -66,207	-31%	-$14.7M	1.77%	10
2015 Q1	$41.9M	Buy	+210,934	New	+$37.4M	1.75%	7
2014 Q4	–	Sell	-62,190	Closed	-$8.16M	–	271
2014 Q3	$8.16M	Sell	62,190 -27,810	-31%	-$3.31M	0.36%	90
2014 Q2	$11.4M	Buy	+90,000	New	+$11.5M	0.52%	71
2014 Q1	–	Sell	-117,681	Closed	-$13.8M	–	238
2013 Q4	$13.8M	Hold	117,681	–	–	0.51%	75
2013 Q3	$12.3M	Hold	117,681	–	–	0.5%	86
2013 Q2	$10.1M	Buy	+117,681	New	+$9.27M	0.41%	91

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Zweig-DiMenna Associates's BHC Position: Q3 2018 in Review

Zweig-DiMenna Associates sold out of Bausch Health (BHC) in Q3 2018, closing a stake of 10,000 shares — an estimated $232K sold.

Zweig-DiMenna Associates first reported a position in BHC in Q2 2013 and held it in 10 quarters. The position peaked at $41.9M in Q1 2015. 332 funds tracked by Wall St. Rank hold BHC as of Q3 2018.

Zweig-DiMenna Associates reported no remaining Bausch Health position as of Q3 2018 after selling out during the quarter.
Zweig-DiMenna Associates sold 10,000 Bausch Health shares in Q3 2018, an estimated $232K.
Zweig-DiMenna Associates first reported a position in Bausch Health in Q2 2013 and held it in 10 quarters.
Zweig-DiMenna Associates's Bausch Health position peaked at $41.9M in Q1 2015.
332 funds tracked by Wall St. Rank held Bausch Health as of Q3 2018.

Based on Zweig-DiMenna Associates's 13F filing for Q3 2018, filed 15 Oct 2018.